These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29059479)

  • 21. Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients.
    Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM;
    Intern Med J; 2015 Jun; 45(6):659-66. PubMed ID: 25732268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.
    Papamichael K; Rivals-Lerebours O; Billiet T; Vande Casteele N; Gils A; Ferrante M; Van Assche G; Rutgeerts PJ; Mantzaris GJ; Peyrin-Biroulet L; Vermeire S
    J Crohns Colitis; 2016 Sep; 10(9):1015-23. PubMed ID: 27022161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.
    Schaufler C; Lerer T; Campbell B; Weiss R; Cohen J; Sayej W; Hyams J
    J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):421-4. PubMed ID: 22395189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Outcomes of Emergency Admissions With Ulcerative Colitis Between 2007 and 2017 in England.
    King D; Rees J; Mytton J; Harvey P; Thomas T; Cooney R; Patel P; Trudgill N
    J Crohns Colitis; 2020 Jul; 14(6):764-772. PubMed ID: 31714573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis.
    Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB
    J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.
    Feuerstein JD; Curran T; Alosilla M; Cataldo T; Falchuk KR; Poylin V
    Dig Dis Sci; 2018 Mar; 63(3):713-722. PubMed ID: 29353444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colectomy with ileostomy for severe ulcerative colitis-postoperative complications and risk factors.
    Schineis C; Lehmann KS; Lauscher JC; Beyer K; Hartmann L; Margonis GA; Michel J; Degro CE; Loch FN; Speichinger F; Kreis ME; Kamphues C
    Int J Colorectal Dis; 2020 Mar; 35(3):387-394. PubMed ID: 31865435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?
    Rizzo G; Pugliese D; Armuzzi A; Coco C
    World J Gastroenterol; 2014 May; 20(17):4839-45. PubMed ID: 24803795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus infection and postoperative complications in patients with ulcerative colitis undergoing colectomy.
    Olaisen M; Rydning A; Martinsen TC; Nordrum IS; Mjønes P; Fossmark R
    Scand J Gastroenterol; 2014 Jul; 49(7):845-52. PubMed ID: 24947587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.
    Reich KM; Chang HJ; Rezaie A; Wang H; Goodman KJ; Kaplan GG; Svenson LW; Lees G; Fedorak RN; Kroeker KI
    Aliment Pharmacol Ther; 2014 Sep; 40(6):629-38. PubMed ID: 25039715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Khalili H; Neovius M; Ekbom A; Ludvigsson JF; Askling J; Chan AT; Olen O
    Am J Gastroenterol; 2016 Nov; 111(11):1614-1620. PubMed ID: 27725646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-TNF-A Therapy about Infliximab and Adalimamab for the Effectiveness in Ulcerative Colitis Compared with Conventional Therapy: A Meta-Analysis.
    Zhou Z; Dai C; Liu WX
    Hepatogastroenterology; 2015 Jun; 62(140):829-37. PubMed ID: 26902011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
    Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study.
    Yamamoto T; Shimoyama T; Umegae S; Matsumoto K
    Aliment Pharmacol Ther; 2016 Mar; 43(6):705-16. PubMed ID: 26762838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
    Feagan BG; Sandborn WJ; Lazar A; Thakkar RB; Huang B; Reilly N; Chen N; Yang M; Skup M; Mulani P; Chao J
    Gastroenterology; 2014 Jan; 146(1):110-118.e3. PubMed ID: 24067881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis.
    Brookes MJ; Waller J; Cappelleri JC; Modesto I; DiBonaventura MD; Bohm N; Mokgokong R; Massey O; Wood R; Bargo D
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32938582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Taxonera C; Iglesias E; Muñoz F; Calvo M; Barreiro-de Acosta M; Busquets D; Calvet X; Rodríguez A; Pajares R; Gisbert JP; López-Serrano P; Pérez-Calle JL; Ponferrada Á; De la Coba C; Bermejo F; Chaparro M; Olivares D; Alba C; Fernández-Blanco I
    Dig Dis Sci; 2017 Feb; 62(2):481-490. PubMed ID: 27995400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe Disease Activity May Predispose Patients to Post-colectomy Duodenitis Associated with Ulcerative Colitis.
    Sonoda A; Yoshimura N; Sako M; Okano S; Saito S; Takazoe M; Furukawa S; Okamoto K; Yamana T; Tachimori H; Fukata M
    Intern Med; 2024 May; 63(10):1337-1343. PubMed ID: 37839884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulcerative colitis-associated hospitalization costs: a population-based study.
    Coward S; Heitman SJ; Clement F; Hubbard J; Proulx MC; Zimmer S; Panaccione R; Seow C; Leung Y; Datta I; Ghosh S; Myers RP; Swain M; Kaplan GG
    Can J Gastroenterol Hepatol; 2015 Oct; 29(7):357-62. PubMed ID: 26079072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study.
    Eriksson C; Rundquist S; Cao Y; Montgomery S; Halfvarson J
    Gut; 2019 Apr; 68(4):623-632. PubMed ID: 29618498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.